AIM
ARNA

Aigen Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Aigen Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,337
Closed -$324K – 1183
2020
Q3 		$324K Buy
+4,337
New +$289K 0.04% 513
2020
Q1 		– Sell
-10,061
Closed -$457K – 1672
2019
Q4 		$457K Buy
+10,061
New +$476K 0.08% 342

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aigen Investment Management's ARNA Position: Q4 2020 in Review

Aigen Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 4,337 shares — an estimated $324K sold.

Aigen Investment Management first reported a position in ARNA in Q4 2019 and held it in 2 quarters. The position peaked at $457K in Q4 2019. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Aigen Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 4,337 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $324K.
  • Aigen Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's Arena Pharmaceuticals Inc position peaked at $457K in Q4 2019.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.